Advertisement

Topics

Clinical Trials About "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds" RSS

18:09 EST 18th November 2018 | BioPortfolio

We list hundreds of Clinical Trials about "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds" on BioPortfolio. We draw our references from global clinical trials data listed on ClinicalTrials.gov and refresh our database daily.

More Information about "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds" on BioPortfolio

We have published hundreds of Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds news stories on BioPortfolio along with dozens of Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds Clinical Trials and PubMed Articles about Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds Companies in our database. You can also find out about relevant Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds Drugs and Medications on this site too.

Showing "Study Assessing Pharmacokinetics Bioavailability Three Novel Triazine Compounds" Clinical Trials 1–25 of 9,700+

Extremely Relevant

Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds

Open-label, randomized, microdose study


Relevant

A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability

A prospective dose escalation, nine period cross-over trial assessing the safety, pharmacokinetics, bioavailability and pharmacodynamics of escalating doses of Remimazolam when administered intranasally as powder and solution in healthy subjects and compared to an intravenous control

An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

The purpose of this study is to evaluate the effect of food on the oral bioavailability of tacrolimus modified release (MR4) capsules together with a standard continental breakfast. The objective is to assess the pharmacokinetics and relative bioavailability with and without food.


Evaluation of Bioavailability of Phenolic Compounds From Oxxynea®

The aim of this study is to evaluate bioavailability and pharmacokinetics of phenolic compounds from Oxxynea®, a blend of fruit and vegetable extracts, in healthy volunteers, during a randomized, double-blind and cross-over trial. After a single dose supplementation, both metabolic profile and urinary excretion will be determined over a 48h-period by means of High-Performance Liquid Chromatography coupled with a tandem mass spectrometry (HPLC-MS) to identify and quantify pheno...

Clinical Study to Evaluate Z7200 Pharmacokinetics Profile

The pharmacokinetics study aims to evaluate the safety of Z7200 (budesonide/formoterol) in comparison with Symbicort Turbohaler (budesonide/formoterol), assessing the bioequivalence of the two products. Namely the study will compare the total systemic bioavailability (as an indicator of safety), and it will compare the pulmonary bioavailability (as a possible surrogate indicator of efficacy). This study will be performed in healthy subjects.

Impact of Food Process and Mastication on Nutrient Bioavailability

This project aims at assessing - the impact of heat treatment on the bioavailability of meat carnosine and amino acids, - the interaction between masticatory efficiency and heat treatment of meat on the bioavailability of carnosine and amino acids - the effect of dietary calcium on tomato lycopene bioavailability.

Oxandrolone in Healthy Adults: A Relative Bioavailability Study

To assess the pharmacokinetics and relative bioavailability of a single dose of approximately 0.1 mg/kg of a medium chain triglyceride (MCT) oil oxandrolone solution vs. tablets in a small cohort of healthy adults.

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

A single center, single dose, open-label, randomized, 3-period, 6-sequence, crossover study conducted in normal healthy subjects to evaluate the effect of a high- and low-fat meal on the pharmacokinetics (PK), bioavailability (BA), and safety of COV155.

Pharmacokinetic, Bioavailability, and Safety Study of COV155 Administered in Healthy Subjects Under Fed and Fasted Conditions

A single center, single dose, open-label, randomized, 3-period, 6-sequence, crossover study conducted in normal healthy subjects to evaluate the effect of a high- and low-fat meal on the pharmacokinetics (PK), bioavailability (BA), and safety of COV155.

Pharmacokinetics Assessing Bioavailability of Gingerols and Shogaols of Five Ginger Extracts

The objective of this study is to assess bioavailability of total gingeroids, free gingerols and shogaols, so as their glucuronide and sulfate metabolites, in the plasma, after consumption of a single dose of 5 different ginger extracts. These five extracts have the same quantity of active substance but with different titration (1.6%, 5%, 39%, 26% and 26% NOP80).

A Study to Evaluate the Relative Bioavailability, Effect of Food, and Gastric pH Modification on the Pharmacokinetics of MLN1117 in Healthy Participants

The purpose of this study is to evaluate the relative bioavailability of a new tablet formulation of MLN1117 (NTM) compared to the MLN1117 Process B capsules (CTM) (Part 1), to assess the effects of food on the oral bioavailability and pharmacokinetics (PK) of MLN1117 (Part 2), and to assess the effects of gastric pH-modifying agent on the PK of MLN1117 in healthy participants (Part 3).

Cannabidiol - an in Vivo Innovative Drug Delivery Study

Basic characterization of the drug delivery system for cannabidiol. A comparative bioavailability study.

Food Effect, Oral & Intravenous Pharmacokinetics and Absolute Bioavailability of BAY1834845 Including Drug-drug Interaction With Methotrexate

This study is planned to explore the effect of food on the oral pharmacokinetics, the intravenous pharmacokinetics and the absolute bioavailability of BAY1834845. Furthermore, this study will investigate the effect of BAY1834845 on the pharmacokinetics of orally administered methotrexate in healthy male subjects.

Bioavailability and Beneficial Properties of Coffee and Cocoa Bioactive Compounds

The aim of this study will be to define the bioavailability and the beneficial properties of coffee bioactive compounds. Moreover, the contribution of cocoa-based products containing coffee to the pool of circulating metabolites will be investigated with the aim of evaluating the effect of the combination of bioactives from different sources. To study the bioavailability of coffee/cocoa bioactive compounds and their effects in cardiometabolic health, the objectives will be: ...

Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants

This study will be conducted to evaluate the relative bioavailability, pharmacokinetics, safety, and tolerability of AVP-923 (dextromethorphan hydrobromide [DM] and quinidine sulfate [Q] capsules) when the contents of a capsule are administered in applesauce or via a nasogastric feeding tube, compared with administration of a capsule in healthy, fasting, adult participants.

Assessment of Pharmacokinetics and Bioavailability of Carbon-14 ([14C])-Labelled Oxytocin

The current study is designed as a phase I multiple dose study to evaluate the pharmacokinetics and bioavailability of [14C]-labelled oxytocin in healthy women.

TMC114-TiDP29-C169: Bioavailability and Pharmacokinetics Trial Comparing Darunavir Pediatric Suspension Formulation to Current Darunavir Tablet

The purpose of this study is to evaluate in healthy volunteers how much and how fast the new suspension compared to the commercial darunavir tablet, given in combination with low-dose ritonavir, are absorbed into the body (called the relative oral bioavailability).

An Open-Label, Staggered Rising Dose Cohort Study Assessing the Pharmacokinetics, Safety, and Tolerance of BI-RG-587 in Combination With Zidovudine in Patients With HIV Infection (CD4+ Cell Count < 400/mm3)

To assess the safety and tolerance of multiple oral doses of nevirapine in combination with zidovudine (AZT); to get information on the pharmacokinetics (blood levels) and dose proportionality of nevirapine/AZT with multiple dosing; to characterize the pattern of virological activity in vivo (in humans) of nevirapine in combination with AZT; to determine whether development of resistance to either drug is slowed by the use of the combination. Drugs now used in treatment for pa...

A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics of TAK-931 in Participants With Advanced Solid Tumors

The purpose of this study is to estimate the relative bioavailability of TAK-931 tablets in reference to powder-in capsule (PIC) and to assess the effect of food and esomeprazole on the pharmacokinetics (PK) of TAK-931 as a tablet.

Subcutaneous Pharmacokinetics Study

Pharmacokinetics, Bioavailability, Safety and Immunogenicity of Single Doses of Belatacept Administered Subcutaneously to Healthy Subjects

Longvida Curcumin Human Pharmacokinetics Study

The primary objective of the study is to characterize the curcumin metabolites of 2 different capsule formulations of curcumin relative to unformulated Curcuma longa extract of Rhizomes including assessing relative bioavailability and absorption/kinetic profile of curcumonoids and their metabolites in human plasma and urine after acute consumption.

Study Will Evaluate the Relative Bioavailability, Safety, and Tolerability of Single Doses of Nifurtimox 30 mg Tablets Exhibiting Different in Vitro Dissolution Characteristics, and to Evaluate the Relative Bioavailability of Nifurtimox 30 mg and 120 mg

Study to assess the relative Bioavailability To assess the relative bioavailability of three formulations of nifurtimox 30 mg tablets exhibiting different in vitro dissolution profiles To assess the pharmacokinetics (PK) of nifurtimox To investigate the safety and tolerability of nifurtimox.

A Study of Zidovudine in HIV-Infected Patients With Liver Disease

To examine the pharmacokinetics (blood levels) and bioavailability of zidovudine (AZT) given to patients with HIV infection and chronic liver disease. The specific aim of the study is to provide data permitting the development of guidelines for use of AZT in patients with mild, moderate, or severe liver disease. AZT is the only antiviral agent that has been shown to be effective in patients with severe HIV infection. However, AZT is largely eliminated from the body through a b...

Study On Bioavailability And Pharmacokinetics Of Various Doses Of Testosterone Administered With And Without Dutasteride

The combination of testosterone and dutasteride is intended for use in hypogonadal men. This study will evaluate the bioavailability and pharmacokinetics of various doses of testosterone administered with and without dutasteride

Study to Evaluate Systemic Bioavailability of Oral OTS167 in Healthy Adult Subjects

The purpose of this study is to determine the indicative bioavailability of a single oral dose of OTS167, and to evaluate the effects of food on OTS167 pharmacokinetics (PK) after oral dosing. Eleven male and female healthy participants aged 45 years and over will be entered into this phase 1, single-centre, double-blind, randomised, cross-over study. The trial is designed to evaluate the bioavailability of OTS167, and the effects of food on pharmacokinetics (PK) of OTS1...


More From BioPortfolio on "Study Assessing Pharmacokinetics and Bioavailability of Three Novel Triazine Compounds"

Advertisement
Quick Search
Advertisement
Advertisement